Clinical Trials
20
Trial Phases
3 Phases
Drug Approvals
2
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (20 trials with phase data)• Click on a phase to view related trials
Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR)
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- First Posted Date
- 2013-08-05
- Last Posted Date
- 2015-06-29
- Lead Sponsor
- Meda Pharmaceuticals
- Target Recruit Count
- 348
- Registration Number
- NCT01915823
- Locations
- 🇺🇸
Clinical Research Center of Alabama,LLC, Birmingham, Alabama, United States
🇺🇸Little Rock Allergy and Asthma Clinical research Center, Little Rock, Alaska, United States
🇺🇸Clinical Research Atlanta, Atlanta, Georgia, United States
Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages >6 Months to <6 Years With AR
- Conditions
- Allergic Rhinitis
- Interventions
- Drug: 205.5 mcg of azelastine hydrochlorideDrug: 137 mcg of azelastine hydrochloride
- First Posted Date
- 2013-06-19
- Last Posted Date
- 2015-06-29
- Lead Sponsor
- Meda Pharmaceuticals
- Target Recruit Count
- 191
- Registration Number
- NCT01880840
- Locations
- 🇺🇸
Clinical Research Center of Alabama,LLC, Birmingham, Alabama, United States
🇺🇸Little Rock Allergy and Asthma Clinical research Center, Little Rock, Alaska, United States
🇺🇸West Coast Clinical Trials, Costa Mesa, California, United States
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
- Conditions
- Allergic Rhinitis
- Interventions
- First Posted Date
- 2013-02-20
- Last Posted Date
- 2015-03-31
- Lead Sponsor
- Meda Pharmaceuticals
- Target Recruit Count
- 405
- Registration Number
- NCT01794741
- Locations
- 🇺🇸
Clinical Research Center of Alabama,LLC, Birmingham, Alabama, United States
🇺🇸Little Rock Allergy and Asthma Clinical research Center, Little Rock, Alaska, United States
🇺🇸West Coast Clinical Trials, Costa Mesa, California, United States
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
- Conditions
- Herpes Labialis
- Interventions
- Drug: acyclovir/hydrocortisone cream
- First Posted Date
- 2012-04-10
- Last Posted Date
- 2014-05-22
- Lead Sponsor
- Meda Pharmaceuticals
- Target Recruit Count
- 54
- Registration Number
- NCT01574612
- Locations
- 🇺🇸
MCS Clinical Trials, Los Angeles, California, United States
🇺🇸Sunshine Research Center, Opa-Locka, Florida, United States
🇺🇸Altus Rsearch,INC, West Palm Beach, Florida, United States
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Seasonal Allergies
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- First Posted Date
- 2011-06-08
- Last Posted Date
- 2011-10-06
- Lead Sponsor
- Meda Pharmaceuticals
- Target Recruit Count
- 617
- Registration Number
- NCT01368445
- Locations
- 🇺🇸
AABI Associates Medical Group, Fountain Valley, California, United States
🇺🇸West Coast Clinical Trials, Long Beach, California, United States
🇺🇸Allergy Research Foundation, Los Angeles, California, United States
- Prev
- 1
- 2
- 3
- 4
- Next